Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.
about
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Reductions of circulating matr ...... t in subjects with acromegaly.
@en
Reductions of circulating matr ...... t in subjects with acromegaly.
@nl
type
label
Reductions of circulating matr ...... t in subjects with acromegaly.
@en
Reductions of circulating matr ...... t in subjects with acromegaly.
@nl
prefLabel
Reductions of circulating matr ...... t in subjects with acromegaly.
@en
Reductions of circulating matr ...... t in subjects with acromegaly.
@nl
P2093
P356
P1476
Reductions of circulating matr ...... t in subjects with acromegaly.
@en
P2093
A N Paisley
C J O'Callaghan
C Parkinson
H S Randeva
J P Monson
K C Lewandowski
M E Roberts
P304
P356
10.1210/JC.2005-2589
P407
P577
2006-08-22T00:00:00Z